LifeStance Health Group Inc header image

LifeStance Health Group Inc

LFST

Equity

ISIN null / Valor 111701745

NASDAQ (2025-11-19)
USD 6.18-0.32%

LifeStance Health Group Inc
UMushroom community rating:

star star star star star
3.00 1 votes No rating yet
NegativeNeutralPositive

About company

LifeStance Health Group Inc is a national mental healthcare services provider that was established in 2017. The company offers a range of mental health treatment services for patients of all ages, bringing together a team of psychiatrists, psychologists, nurse practitioners, and licensed therapists. LifeStance is dedicated to providing compassionate care and treatment tailored to the specific needs of each individual patient. The company focuses on clinical excellence, collaboration with other healthcare providers, data utilization for service customization, patient empowerment, and integrated care practices in a safe and supportive environment.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.10.2025):

LifeStance Health Group Inc reported strong financial results for the first quarter of 2025, showcasing significant growth in revenue, an expanding clinician base, and a return to profitability. These results highlight the company's continued commitment to enhancing access to mental healthcare services.

Revenue Growth

Revenue increased by 11% year-over-year to $333.0 million, driven by higher visit volumes and improvements in revenue per visit.

Clinician Base Expansion

The number of clinicians grew by 10% to 7,535, with a net increase of 152 clinicians in the first quarter, supporting the rise in patient visits.

Increased Visit Volumes

First quarter visit volumes rose by 10% to reach 2.1 million, reflecting enhanced patient engagement and service utilization.

Return to Profitability

Net income turned positive at $0.7 million, a significant improvement from a net loss of $21.1 million in the same period last year.

Improved EBITDA

Adjusted EBITDA saw a 25% increase to $34.6 million, up from $27.7 million in the previous year, indicating stronger operational performance.

Full Year Guidance

For the full year 2025, LifeStance expects revenues between $1.40 billion and $1.44 billion, a Center Margin of $440 million to $464 million, and Adjusted EBITDA ranging from $130 million to $150 million.

Summarized from source with an LLMView Source

Key figures

-14.6%1Y
24.1%3Y
%5Y

Performance

45.3%1Y
56.4%3Y
71.5%5Y

Volatility

Market cap

2404 M

Market cap (USD)

Daily traded volume (Shares)

2,079,410

Daily traded volume (Shares)

1 day high/low

7.465 / 7.26

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Benjamin Gan Cheng Ng
United Kingdom, 07 Nov 2025
star star star star star
Decent

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.22%EUR 26.48
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%EUR 9.03
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%EUR 26.45
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%EUR 110.65
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.79%EUR 46.69
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%EUR 39.52
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%EUR 35.30
AbbVie Inc
AbbVie Inc AbbVie Inc Valor: 20145667
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 232.91
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 24.88
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%USD 70.53